MiMedx Group, Inc.
MDXG
$6.96
-$0.21-2.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -5.06% | 10.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.06% | 10.53% | |||
| Cost of Revenue | -2.08% | 10.36% | |||
| Gross Profit | -5.73% | 10.57% | |||
| SG&A Expenses | -1.83% | 12.78% | |||
| Depreciation & Amortization | -48.70% | 0.52% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.21% | 12.62% | |||
| Operating Income | -25.99% | -2.72% | |||
| Income Before Tax | -23.44% | -1.49% | |||
| Income Tax Expenses | -58.30% | 7.62% | |||
| Earnings from Continuing Operations | -5.58% | -5.59% | |||
| Earnings from Discontinued Operations | -- | -100.00% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.58% | -8.12% | |||
| EBIT | -25.99% | -2.72% | |||
| EBITDA | -18.81% | 12.07% | |||
| EPS Basic | -5.73% | -8.17% | |||
| Normalized Basic EPS | -24.27% | -3.21% | |||
| EPS Diluted | -4.79% | -2.72% | |||
| Normalized Diluted EPS | -24.21% | -3.85% | |||
| Average Basic Shares Outstanding | 0.18% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.29% | 0.59% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||